oseltamivir has been researched along with ephedrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Izumi, Y; Narahashi, T; O'Dell, K; Tokuda, K; Zorumski, C | 1 |
1 review(s) available for oseltamivir and ephedrine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for oseltamivir and ephedrine
| Article | Year |
|---|---|
Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants.
Topics: Animals; Antiviral Agents; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Drug Interactions; Enzyme Inhibitors; Ephedrine; Ethanol; Excitatory Postsynaptic Potentials; Hippocampus; Locomotion; Long-Term Synaptic Depression; Male; Neuraminidase; Oseltamivir; Rats; Rats, Sprague-Dawley; Risk Assessment; Time Factors | 2008 |